Shen; Beifen

Patent Applications and Registrations

Patent applications and USPTO patent grants for Shen; Beifen.The latest application filed is for "human tim-3 fusion protein capable of blocking tim-3 signaling pathway".

Company Profile

0.8.8

Shen; Beifen - Beijing CN
Shen; Beifen - Bejing CN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Anti-C5a binding moieties with high blocking activity Grant 10,774,136 - Guo , et al. Sept	2020-09-15
Human Tim-3 fusion protein capable of blocking Tim-3 signaling pathway Grant 9,644,020 - Han , et al. May 9, 2	2017-05-09
Human Tim-3 Fusion Protein Capable Of Blocking Tim-3 Signaling Pathway App 20170029485 - HAN; Gencheng ; et al.	2017-02-02
Anti-C5a Binding Moieties With High Blocking Activity App 20170002067 - GUO; Renfeng ; et al.	2017-01-05
Anti-C5a binding moieties with high blocking activity Grant 9,458,233 - Guo , et al. October 4, 2	2016-10-04
Anti-C5a Binding Moieties With High Blocking Activity App 20150266949 - GUO; Renfeng ; et al.	2015-09-24
Anti-C5A binding moieties with high blocking activity Grant 9,073,983 - Guo , et al. July 7, 2	2015-07-07
Anti-c5a Binding Moieties With High Blocking Activity App 20140314772 - GUO; Renfeng ; et al.	2014-10-23
Anti-C5a binding antibodies with high block activity Grant 8,802,096 - Guo , et al. August 12, 2	2014-08-12
Anti-C5A Binding Moieties with High Blocking Activity App 20120231008 - Guo; Renfeng ; et al.	2012-09-13
Use of Trap Protein Per se as an Active Ingredient for the Manufacture of a Medicament for the Treatment of Staphylococcus Aureus Infection App 20090305975 - Yang; Guang ; et al.	2009-12-10
Substituted 6-membered N-heterocyclic compounds and method for their use as neurological regulator Grant 7,304,057 - Li , et al. December 4, 2	2007-12-04
Substituted 5-membered n-heterocyclic compounds and their uses for treating or preventing neurodegenerative diseases Grant 7,262,183 - Li , et al. August 28, 2	2007-08-28
Substituted 5-membered n-heterocyclic compounds and their uses for treating or preventing neurodegenerative diseases App 20050171166 - Li, Song ; et al.	2005-08-04
Substituted 6−membered n−heterocyclic compounds and their uses as neurological regulator App 20050130958 - Li, Song ; et al.	2005-06-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.